Global Precision Medicine Market Report 2020 - Market Size, Share, Price, Trend and Forecast is a professional and in-depth study on the current state of the global Precision Medicine industry.
Non-Oncology Precision Medicine market is segmented by Ecosystem, and by Application. Players, stakeholders, and other participants in the global Non-Oncology Precision Medicine market will be able to gain the upper hand as they use the report as a powerful resource.
The global precision medicine market is expected to grow from $62.75 billion in 2020 to $72.58 billion in 2021 at a compound annual growth rate (CAGR) of 15.7%.
The global companion diagnostics market is anticipated to grow at a CAGR of 13.29%, and is estimated to reach $15441.90 million by 2030. Get Free Sample Report.
This report focuses on the global Precision Medicine Software status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Precision Medicine Software development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
Global Precision medicine Market Information by Ecosystem (diagnostic companies, clinical laboratories), by Sub Markets (Companion diagnostic, biomarker based test), by Therapeutics (cardiovascular disease, central nervous system) - Forecast to 2027
The global Bioinformatics Market is primarily driven by the increasing adoption of next-generation sequencing (NGS) technologies and rising focus on precision medicine.
The global oncology precision medicine market was estimated to be worth $49.4 billion in 2021, and it is expected to reach $ 124.84 billion by 2030, expanding at a CAGR of 10.85% from 2021 to 2030 For more info - https://straitsresearch.com/report/oncology-precision-medicine-market
According to the latest research report by IMARC Group, The United States precision medicine market size is projected to exhibit a growth rate (CAGR) of 7.10% during 2024-2032. More Info:- https://www.imarcgroup.com/united-states-precision-medicine-market
Global artificial intelligence (ai) in precision medicine market size is expected to reach $6.86 Bn by 2028 at a rate of 30.4%, segmented as by component, hardware, software, service
The Global Companion Diagnostics Market is expected to witness growth at a CAGR of 12.84% during the forecast period 2022-2028. Request a Free Sample Report.
The report Personalized Medicine Market analyzes the Market status, Market share, growth rate, future trends, Market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
AI in Precision Medicine Market by Offering (Hardware, Software, Services), Technology (Machine Learning, Natural Language Processing, Context-aware Computing, Computer Vision), Therapeutic Application (Oncology, Cardiology, Neurology, Respiratory, Others), and Region (North America, Europe, Asia Pacific, RoW) – Global Forecast to 2027
The global artificial intelligence (AI) in precision medicine market is expected to grow from $1.41 billion in 2022 to $1.82 billion in 2023 at a compound annual growth rate (CAGR) of 29.3%.
In 2022, the global revenue generated by the proteomics market reached approximately US$ 30.8 billion, and it is anticipated to exhibit a robust compound annual growth rate (CAGR) of 17.6%, projecting a valuation of US$ 181.5 billion by the conclusion of 2033. According to the evaluation conducted by Persistence Market Research, the reagents and kits segment is poised to dominate with the highest market value, reaching US$ 18.4 billion by 2023. Contributing to around 6.0% of the total revenue in the global omics market, valued at approximately US$ 514.3 billion by the close of 2022, sales in the proteomics market demonstrate a substantial presence. Over the past eight years, from 2014 to 2022, the global proteomics market has exhibited a historic CAGR of 15.5%.
DecisionDatabases.com, a market research firm adds a report Global Computational Medicine Industry 2016 Market Research Report to its repository. The report gives a detailed account of the industry - Sales, Revenue Size, Share, Exports, Imports, and Production Volume etc.
Get more details @ http://bit.ly/2l3rNQ4 Key industry players contributing to global precision medicine market share include Pfizer, Roche, Covance, Novartis, Qiagen, Biocrates Life Sciences, Teva Pharmaceutical, Nanostring Technologies, Laboratory Corporation of America Holdings, Tepnel Pharma Services, Intomics, Ferrer InCode, Silicon Biosystems, Eagle Genomics, Medtronic, and Quest Diagnostics
The latest report published by Persistence Market Research titled “Global Market Study on Precision Medicine: Drug Discovery Technology Segment Estimated to Witness 0.1% Decline in Market Share Between 2016 and 2024“. projects some of the crucial aspects of the global precision medicine market after an in-depth research. The report assures that the market will grow manifold and it will register a 14.7% CAGR between 2016 and 2024.
The latest report published by Persistence Market Research titled “Global Market Study on Precision Medicine: Drug Discovery Technology Segment Estimated to Witness 0.1% Decline in Market Share Between 2016 and 2024“. projects some of the crucial aspects of the global precision medicine market after an in-depth research. The report assures that the market will grow manifold and it will register a 14.7% CAGR between 2016 and 2024.
DecisionDatabases.com adds a report on Global Fumaric Acid Market Market Growth 2019-2024. This research study is segmented on the bases of applications, technology and geography. Report Link - https://www.decisiondatabases.com/ip/19801-fumaric-acid-market-analysis-report
The latest report published by Persistence Market Research titled “Global Market Study on Precision Medicine: Drug Discovery Technology Segment Estimated to Witness 0.1% Decline in Market Share Between 2016 and 2024“. projects some of the crucial aspects of the global precision medicine market after an in-depth research. The report assures that the market will grow manifold and it will register a 14.7% CAGR between 2016 and 2024.
The major players in the precision medicine market are Qiagen, Novartis AG, Medtronic, AstraZeneca plc., Quest Diagnostics, Thermo Fisher Scientific Inc...@@ https://bit.ly/2XCz1CE
Triton Market Research | Artificial Intelligence in the Healthcare Market is expected to display an upward trend in terms of revenue and estimated to grow at a CAGR of 40.48% from the forecasting years of 2019 to 2027.
Precision Medicine Market size was over USD 39 billion in 2015, and is anticipated to grow at 10.5% CAGR from 2016 to 2023. Get more details @ https://goo.gl/y9VxzK
The latest report published by Persistence Market Research titled “Global Market Study on Precision Medicine: Drug Discovery Technology Segment Estimated to Witness 0.1% Decline in Market Share Between 2016 and 2024“. projects some of the crucial aspects of the global precision medicine market after an in-depth research. The report assures that the market will grow manifold and it will register a 14.7% CAGR between 2016 and 2024.
The global expansion of the medicine industry will expand the canvas of the global precision market. Larger investments, better infrastructure, simplified approval process of drugs along with companion diagnostics will impact the structure of the entire climate of the global precision medicine market.
DNA sequencing is a technology in which several DNA strands can be sequenced through massive parallelization. This sequencing includes both Sanger’s method of sequencing and non-Sanger’s methods of sequencing. Read More@ https://www.alliedmarketresearch.com/dna-sequencing-market
Get more details @ http://bit.ly/2ekRPfD Some of the major players of global precision medicine market are Intomics, F. Hoffmann-La Roche, NanoString Technologies, Laboratory Corporation of America Holdings, Biocrates Life Sciences, Teva Pharmaceutical, Tepnel Pharma Services, Novartis, Silicon Biosystems, Quest Diagnostics and Ferrer InCode.
Get more details @ http://bit.ly/2ekRPfD Some of the major players of global precision medicine market are Intomics, F. Hoffmann-La Roche, NanoString Technologies, Laboratory Corporation of America Holdings, Biocrates Life Sciences, Teva Pharmaceutical, Tepnel Pharma Services, Novartis, Silicon Biosystems, Quest Diagnostics and Ferrer InCode.
Get more details @ http://bit.ly/2ekRPfD Key industry players contributing to global precision medicine market share include Pfizer, Roche, Covance, Novartis, Qiagen, Biocrates Life Sciences, Teva Pharmaceutical, Nanostring Technologies, Laboratory Corporation of America Holdings, Tepnel Pharma Services, Intomics, Ferrer InCode, Silicon Biosystems, Eagle Genomics, Medtronic, and Quest Diagnostics.
The Global Precision Oncology market research report provides an insightful analysis of the current market, along with a futuristic perspective on the growth of the market.
Electroceuticals/Bioelectric Medicine Market is expected to grow in upcoming years due to factors such as rise in geriatric population across the world, increase in regulatory approvals for new and advanced electroceuticals and rise in investment and funds for the development in new therapies.
The latest report by Precision Business Insights, titled “Personalized Medicine Market” covers complete information on market size, share, growth, trends, segment analysis, key players, drivers, and restraints.
The Biomarkers Market is experiencing significant growth, driven by the rising prevalence of chronic diseases and advancements in personalized medicine. The market was valued at US$ 51.2 billion in 2022 and is projected to expand at a CAGR of 10.4% from 2023 to 2031, reaching more than US$ 125.6 billion by 2031.
The global medical dynamometer market is predicted to grow at a CAGR of 5.76% over the forecast period of 2024 to 2032. Get more insights into our latest blog
As per Renub Research, report titled “Colonoscopy Devices Market Global Forecast 2021-2027, Industry Trends, Growth, Impact of COVID-19, Opportunity Company Analysis” the Global Colonoscopy Devices Market is expected to be USD 2.1 Billion by 2027. Globally, Colonoscopy devices are used to examine the inside of the colon using a colonoscope inserted into the rectum. Wherein, colonoscope implies a thin, tube-like instrument with a light and a lens for viewing. Besides, a colonoscopy may also have a tool to remove tissue to be checked under a microscope for signs of disease. In addition, the gastroenterologist carefully guides the colonoscope in various directions to look inside the colon. After that, a picture from the camera appears on a monitor to provide a clear, magnified view of the colon lining.
The global Radiopharmaceuticals/Nuclear Medicine Market was valued at US$ 5605 Million in 2022 and is anticipated to grow at US$ 9327 Million by 2029 recording a CAGR of 9.3% during the forecast period 2023-2029. Request sample report at https://www.precisionbusinessinsights.com/request-sample/?product_id=17441
The global endoscopy guidewire market is projected to register growth at a CAGR of 5.40% during forecast the period 2023-2032. Get more insights into the blog
The global surgical robotics market is projected to record a CAGR of 9.29% during 2024-2032 and is set to garner $25644.37 by 2032. Request Free Sample Report
According to Renub Research report, tittled “Autoimmune Disease Diagnostic Market, Size. Global Forecast 2021-2027, Industry Trends, Impact of COVID-19, Opportunity Company Analysis” the Autoimmune Disease Diagnostics Market will be USD 8.02 Billion by 2027. Autoimmune disorders are a species of more than 80 chronic diseases, out of which multiple sclerosis, Systemic Lupus Erythematosus (SLE), rheumatoid arthritis, and type I diabetes are the most common autoimmune diseases. An autoimmune disease transfers to a condition wherein the immune system destroys and attacks healthy cells, organs of the body, and tissues. In the longer run, it can further lead to abnormal growth of an organ and changes in organ function.
The global anesthesiologists market was valued at $16.1 billion in 2017. Read Report https://www.thebusinessresearchcompany.com/report/anesthesiologists-global-market-report-2018
The Veterinary Medicine Market Report provides an exhaustive analysis of the growth drivers, current trends, restraining forces, and opportunities present in the market.
The global companion diagnostics market is anticipated to grow at a CAGR of 13.29%, and is estimated to reach $15441.90 million by 2030. Get Free Sample Report.
The research firm Contrive Datum Insights has just recently added to its database a report with the heading global Alternative Medicines and Therapies Market .Both primary and secondary research methodologies have been utilised in order to conduct an analysis of the worldwide Alternative Medicines and Therapies Market . In order to provide a comprehensive comprehension of the topic at hand, it has been summed up using appropriate and accurate market insights. According to Contrive Datum Insights, this worldwide comprehensive report is broken up into several categories in order to present the data in a way that is understandable, succinct, and presented in a professional manner.Natural treatments that are different from traditional medications or drugs are referred to as alternative medicine and therapies. A variety of natural and non-mineral, non-vitamin, and alternative medicine therapies are available.
Global Market Insights Inc. presents the Mice Model Market provides a detailed overview of major drivers, restraints, challenges, opportunities, current industry trends and strategies impacting the global market along with estimates and forecast of revenue.
Request for sample research report at https://precisionbusinessinsights.com/request-sample?product_id=17135 The global regenerative medicine market size was valued US$ 8425 Mn in the year 2020 and is anticipated to grow at US$ 21871 Mn till 2027 witnessing a CAGR of 14.6% over the forecast period 2021-2027. Market players took initiatives for increasing finance for R&D of regenerative medicine is projected to support the market growth. Furthermore industries are working together to reinforce their R&D capabilities for the developing as well as commercializing pioneering therapies for making
According to Renub Research analysis Global Molecular Diagnostics Market is likely to surpass US$ 22.5 Billion by the end of year 2025. By Application (2019 - 2025). Access full Research: https://www.renub.com/global-molecular-diagnostics-market-and-future-forecast-2010-2014-334-p.php